Daniel Janney

Affiliations

  • Director at Krystal Biotech Inc. (KRYS), 2024-07-01
  • Director at Allakos Inc. (ALLK), 2023-05-30
  • Large Shareholder at Tyra Biosciences Inc. (TYRA), 2021-09-17
  • Director at Esperion Therapeutics Inc. (ESPR), 2021-05-28
  • Director at Sutro Biopharma Inc. (STRO), 2019-06-19
  • Director at Viveve Medical Inc. (VIVE), 2019-01-02
  • Other at Neothetics Inc. (NEOT), 2015-12-30
  • Large Shareholder at Zs Pharma Inc. (ZSPH), 2015-06-09
  • Large Shareholder at Atyr Pharma Inc (LIFE), 2015-05-15
  • Large Shareholder at Carbylan Therapeutics Inc. (CBYL), 2015-04-14
  • Large Shareholder at Trevena Inc (TRVN), 2014-12-10
  • Large Shareholder at Applied Genetic Technologies Corp (AGTC), 2014-11-19
  • Large Shareholder at Immune Design Corp. (IMDZ), 2014-07-31
  • Large Shareholder at Aerie Pharmaceuticals Inc (AERI), 2014-07-18
  • Large Shareholder at Ellie Mae Inc (ELLI), 2011-04-21
  • Large Shareholder at Acelrx Pharmaceuticals Inc (ACRX), 2011-02-18
  • Large Shareholder, Director at Anesiva Inc. (ANSV), 2010-01-08
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALLK $5.02 475,000 Large Shareholder, Director 2,546,147 2022-09-21 Filing
ALLK $18.00 250,000 Large Shareholder, Director 11,519,200 2018-07-23 Filing
KRYS $10.00 200,000 Director 330,590 2017-09-22 Filing
VIVE $4.00 500,000 Director 1,381,955 2017-03-17 Filing
VIVMF $5.00 200,000 Director 881,954 2016-06-17 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KRYS $128.53 10,000 Director 107,362 2023-06-09 Filing
KRYS $128.84 5,000 Director 117,362 2023-06-09 Filing
KRYS $129.29 3,935 Director 122,362 2023-06-09 Filing
KRYS $127.86 5,000 Director 126,297 2023-06-08 Filing
KRYS $127.96 10,000 Director 131,297 2023-06-08 Filing